111 Capital Invests $302,000 in Amdocs Limited $DOX

Key Points

• 111 Capital has invested approximately $302,000 in Amdocs Limited by purchasing 3,310 shares in the second quarter.
• Amdocs announced a quarterly dividend of $0.527 per share, equivalent to an annualized dividend of $2.11 and a yield of 2.6%.
• Analysts currently rate Amdocs with a consensus of "Moderate Buy" and a target price of $108.00, despite recent downgrades from some firms.

111 Capital purchased a new position in shares of Amdocs Limited (NASDAQ:DOX - Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,310 shares of the technology company's stock, valued at approximately $302,000.

Several other institutional investors also recently modified their holdings of DOX. Ascent Group LLC increased its holdings in Amdocs by 4.5% in the second quarter. Ascent Group LLC now owns 8,734 shares of the technology company's stock valued at $797,000 after purchasing an additional 378 shares during the period. Two Point Capital Management Inc. acquired a new stake in Amdocs in the second quarter valued at $2,667,000. Mirae Asset Global Investments Co. Ltd. increased its holdings in Amdocs by 15.6% in the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 10,555 shares of the technology company's stock valued at $963,000 after purchasing an additional 1,421 shares during the period. Lecap Asset Management Ltd. acquired a new stake in Amdocs in the second quarter valued at $988,000. Finally, USA Financial Formulas increased its holdings in Amdocs by 31.4% in the second quarter. USA Financial Formulas now owns 3,187 shares of the technology company's stock valued at $291,000 after purchasing an additional 761 shares during the period. 92.02% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts recently weighed in on the company. Wolfe Research assumed coverage on Amdocs in a report on Tuesday, July 8th. They issued an "outperform" rating for the company. Wall Street Zen downgraded Amdocs from a "buy" rating to a "hold" rating in a report on Friday. Finally, Weiss Ratings restated a "hold (c+)" rating on shares of Amdocs in a report on Saturday, September 27th. Three analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, Amdocs has a consensus rating of "Moderate Buy" and a consensus target price of $108.00.

Amdocs Stock Performance

Shares of Amdocs stock opened at $82.43 on Tuesday. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 0.23. The business has a 50-day moving average price of $85.13 and a two-hundred day moving average price of $87.94. Amdocs Limited has a 1-year low of $78.61 and a 1-year high of $95.41. The company has a market cap of $9.31 billion, a P/E ratio of 16.72, a PEG ratio of 1.37 and a beta of 0.51.

Amdocs (NASDAQ:DOX - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The technology company reported $1.72 earnings per share for the quarter, topping analysts' consensus estimates of $1.71 by $0.01. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.The firm had revenue of $1.14 billion during the quarter, compared to the consensus estimate of $1.13 billion. During the same period last year, the business posted $1.62 EPS. The business's revenue was down 8.4% compared to the same quarter last year. As a group, analysts anticipate that Amdocs Limited will post 6.21 EPS for the current year.

Amdocs Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be given a dividend of $0.527 per share. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend is Tuesday, September 30th. Amdocs's dividend payout ratio is 42.80%.

Amdocs Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.